Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Microsoft
MSFT
|
+$351M |
| 2 |
Netflix
NFLX
|
+$343M |
| 3 |
Berkshire Hathaway Class A
BRK.A
|
+$293M |
| 4 |
Nike
NKE
|
+$186M |
| 5 |
Delta Air Lines
DAL
|
+$177M |
Top Sells
| 1 |
Meta Platforms (Facebook)
META
|
+$1.33B |
| 2 |
Tesla
TSLA
|
+$344M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$306M |
| 4 |
NVIDIA
NVDA
|
+$281M |
| 5 |
Boeing
BA
|
+$251M |
Sector Composition
| 1 | Technology | 19.27% |
| 2 | Healthcare | 18.45% |
| 3 | Consumer Discretionary | 12.35% |
| 4 | Consumer Staples | 10.15% |
| 5 | Industrials | 9.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1876
German American Bancorp
GABC
$1.52B
| $1.98M | ﹤0.01% |
73,048
+5,749
| +9% | +$156K |
|
1877
MannKind Corp
MNKD
$1.65B
| $1.97M | ﹤0.01% |
477,645
-198,700
| -29% | -$821K |
|
1878
Silicon Laboratories
SLAB
$4.41B
| $1.97M | ﹤0.01% |
+16,998
| New | +$1.97M |
|
1879
iShares S&P 500 Value ETF
IVE
$40.9B
| $1.97M | ﹤0.01% |
12,800
-16,100
| -56% | -$2.48M |
|
1880
Marten Transport
MRTN
$946M
| $1.97M | ﹤0.01% |
99,707
+66,507
| +200% | +$1.31M |
|
1881
LivePerson
LPSN
$65.7M
| $1.96M | ﹤0.01% |
504,642
-156,158
| -24% | -$607K |
|
1882
FlexShares High Yield Value-Scored Bond Index Fund
HYGV
$1.25B
| $1.96M | ﹤0.01% |
49,300
+29,900
| +154% | +$1.19M |
|
1883
Northeast Community Bancorp
NECB
$263M
| $1.96M | ﹤0.01% |
132,500
-8,300
| -6% | -$123K |
|
1884
Kodak
KODK
$481M
| $1.95M | ﹤0.01% |
464,045
+93,996
| +25% | +$396K |
|
1885
Cannae Holdings
CNNE
$1.14B
| $1.95M | ﹤0.01% |
104,700
-8,705
| -8% | -$162K |
|
1886
Vanguard Energy ETF
VDE
$7.33B
| $1.95M | ﹤0.01% |
15,400
+11,300
| +276% | +$1.43M |
|
1887
Equity Bancshares
EQBK
$784M
| $1.95M | ﹤0.01% |
80,900
-3,600
| -4% | -$86.6K |
|
1888
iShares S&P 100 ETF
OEF
$22.7B
| $1.95M | ﹤0.01% |
9,700
-3,000
| -24% | -$602K |
|
1889
Grid Dynamics Holdings
GDYN
$644M
| $1.95M | ﹤0.01% |
159,800
+16,806
| +12% | +$205K |
|
1890
First Trust North American Energy Infrastructure Fund
EMLP
$3.3B
| $1.95M | ﹤0.01% |
73,600
-4,700
| -6% | -$124K |
|
1891
iShares MSCI China ETF
MCHI
$8.37B
| $1.93M | ﹤0.01% |
+44,600
| New | +$1.93M |
|
1892
Arcellx
ACLX
$4.29B
| $1.93M | ﹤0.01% |
53,800
-290,867
| -84% | -$10.4M |
|
1893
AMREP Corp
AXR
$135M
| $1.92M | ﹤0.01% |
114,400
+1,600
| +1% | +$26.9K |
|
1894
iShares Core S&P US Value ETF
IUSV
$22B
| $1.92M | ﹤0.01% |
25,700
-1,500
| -6% | -$112K |
|
|
DEN
1895
DELISTED
Denbury Inc.
DEN
| $1.91M | ﹤0.01% |
+19,500
| New | +$1.91M |
|
1896
Vanguard Small-Cap ETF
VB
$67.5B
| $1.91M | ﹤0.01% |
+10,100
| New | +$1.91M |
|
|
PPBI
1897
DELISTED
Pacific Premier Bancorp
PPBI
| $1.91M | ﹤0.01% |
+87,728
| New | +$1.91M |
|
1898
Inovio Pharmaceuticals
INO
$121M
| $1.9M | ﹤0.01% |
407,458
-45,565
| -10% | -$213K |
|
1899
Xeris Biopharma Holdings
XERS
$1.21B
| $1.9M | ﹤0.01% |
1,022,040
+163,346
| +19% | +$304K |
|
1900
Tarsus Pharmaceuticals
TARS
$2.14B
| $1.9M | ﹤0.01% |
106,900
-7,600
| -7% | -$135K |
|